Find similar content

Source channel @githubtrending · Post #14772 · Jun 1

#cplusplus#cache#cpp#database#fibers#in_memory#in_memory_database#key_value#keydb#memcached#message_broker#multi_threading#nosql#redis#valkey#vector_search Dragonfly is a modern in-memory data store compatible with Redis and Memcached, offering up to 25 times higher throughput and better cache efficiency while using up to 80% fewer resources. It scales well with larger servers, supports many Redis commands, and features a unique, memory-efficient cache and fast snapshotting. Dragonfly provides low latency, high performance, and is easy to configure with familiar Redis options. Its design ensures atomic operations and efficient resource use, making it ideal for fast, cost-effective cloud applications needing real-time data access and high scalability. This means you get faster, more efficient caching and data handling with minimal changes to your existing setup[5][2][4]. https://github.com/dragonflydb/dragonfly

Hashtags

#cplusplus #cache #cpp #database #fibers #in_memory #in_memory_database #key_value #keydb #memcached #message_broker #multi_threading #nosql #redis #valkey #vector_search

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment